Tag: submissions

Implementing Effective Controls to Prevent ERES System Operation Failures The increasing reliance on electronic records and electronic signatures (ERES) in the pharmaceutical industry underscores the importance of robust controls. ERES…

Risk-Based Remediation for Inadequate ERES Controls During System Upgrade In the rapidly evolving landscape of pharmaceutical compliance, the implementation of Electronic Records and Electronic Signatures (ERES) controls during system upgrades…

Managing Uncontrolled Hybrid Paper-Electronic Workflows During Validation Lifecycle As digital transformation accelerates within pharmaceutical manufacturing, uncontrolled hybrid paper-electronic workflows pose significant regulatory compliance risks, particularly concerning 21 CFR Part 11.…

Mitigating Misuse of Electronic Signatures During Inspection Walkthroughs: A Comprehensive Playbook The increasing reliance on electronic signatures in the pharmaceutical sector brings both efficiency and regulatory challenges, particularly during inspection…

Addressing Record Retention Failures during System Operations – A Comprehensive Playbook Record retention failures during system operation pose significant risks to data integrity and compliance within the pharmaceutical industry. These…

Addressing Record Retention Failures During System Operation: An Inspection-Ready Playbook In the pharma manufacturing landscape, record retention failures can lead to significant operational challenges, especially during inspections. These failures can…

Managing Compliance Gaps in Hybrid Paper-Electronic Workflows During an Audit In the evolving landscape of pharmaceutical manufacturing, hybrid paper-electronic workflows pose significant challenges, particularly during compliance audits. When these workflows…

Addressing ERES Control Failures During the Validation Lifecycle to Avoid Part 11 Findings In today’s pharmaceutical landscape, the integrity of electronic records and electronic signatures (ERES) is paramount. Failing to…

Enhancing System Access Controls to Avoid Part 11 Findings During Inspections The integrity of pharmaceutical manufacturing processes heavily relies on stringent system access controls, especially in the context of electronic…

Managing Uncontrolled Hybrid Paper-Electronic Workflows During System Upgrades During system upgrades, the integrity of hybrid paper-electronic workflows can often become compromised, leading to potential non-compliance and data integrity issues. In…

Mitigating Weak System Access Controls During Validation Lifecycle: A CAPA Playbook In an era of heightened regulatory scrutiny, pharmaceutical companies are increasingly faced with challenges related to system access controls…

Addressing Record Retention Failures in the Validation Lifecycle and Developing a CAPA Strategy Record retention failures during the validation lifecycle are a pressing concern for pharmaceutical professionals. From production to…